Women with a family history of breast cancer could be offered preventative medication under new NHS plans
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Tuesday 15 January 2013
Around half a million women with a strong family history of breast cancer should be offered drugs to prevent the disease from developing, according to official advice issued today.
The National Institute for Clinical Excellence says in draft guidance that all women over 30 at high risk of breast cancer should be given the opportunity to take drugs to reduce it.
It is the first time that women have been advised to take preventive drug treatment for cancer and represents what one charity called a "historic shift".
Breast cancer is the most common cancer in the UK affecting about 50,000 women and 400 men a year. Most women get the disease by chance and its incidence increases with age.
However, having a family history of breast or ovarian cancer increases the risk. Around 1 per cent of women over 30 are deemed to be at high risk and could be offered tamoxifen or a similar drug raloxifen for five years.
Experts estimate that for every 1000 high risk women who took the drug there would be 20 fewer breast cancers. However, the side effects of the drug, which include an increased risk of blood clots would need to be balanced against the benefits.
Neither drug is yet licensed for preventive treatment . The draft recommendation is out for consultation and final guidance will be published in the summer, NICE said.
Chris Askew, chief executive of the charity Breakthrough Breast Cancer, said: "This draft guideline represents a historic step for the prevention of breast cancer. It is the first time drugs have ever been recommended fro reducing breast cancer in the UK."
The guidance also recommends that high risk women be offered mammography screening tests every year, instead of every three years, and genetic tests to establish if they are carrying a faulty gene, such as BRCA1 or BRCA2, which greatly increases the risk of breast cancer.
The battle for control of Stieg Larsson's £30m legacy
Geoffrey Macnab does not like the comedian's big screen debut
Look beyond the usual shows for the best festive telly
Michelle Nijhuis' daughter insists (s)he is, and she learnt a valuable lesson on gender in books
newsFormer soldier taped 33 of the animals to the floor and then stamped on them one by one
Life & Style blogs
America's 'virgin births'? One in 200 mothers 'became pregnant without having sex'
GTA 5: Rockstar bans gamers stealing in-game money worth millions
There's a snake in my hat! Snakes in tiny headgear becomes latest pet trend
Microsoft announces first exclusive Xbox One content: a documentary on the worst video game ever
Potential revolution in cancer treatment voted breakthrough of the year by scientists
- 1 Sun will 'flip upside down' within weeks, says Nasa
- 2 Christmas comes early: Justin Bieber is 'retiring from music'
- 3 Iain Duncan Smith leaves Commons food banks debate early
- 4 Cycle death inquest: Boyfriend hugs driver of 32 tonne tipper truck that killed his girlfriend
- 5 Burglar steals video tapes of child abuse, hands them into police
- < Previous
- Next >
£40000 - £55000 per annum: Pro-Recruitment Group: This Big 4 giant is seeking ...
£35000 - £50000 per annum: Pro-Recruitment Group: Do you have personal tax exp...
£22000 - £37000 per annum: Capita Education Resourcing Permanent Team: This se...
£27000 - £30000 per annum: Capita Education Resourcing Permanent Team: Capita ...